Folate-displaying exosome mediated cytosolic delivery of siRNA avoiding endosome trapping

Area of Science:

• Biotechnology
• Nanotechnology
• Oncology

Background:

• Folate receptor (FA) is overexpressed on cancer cells, making it a target for cancer therapy.
• Previous attempts at direct siRNA delivery via folate receptor-mediated endocytosis have faced clinical limitations.
• RNA nanotechnology has been used to create FA-displaying exosomes for targeted delivery.

Purpose of the Study:

• To elucidate the mechanism behind the therapeutic efficacy of FA-displaying exosomes for cancer treatment.
• To investigate the pathway of siRNA delivery mediated by FA-exosome complexes.
• To demonstrate the potential of FA-exosomes in overcoming endosomal entrapment for enhanced gene silencing.

Main Methods:

• Utilizing RNA nanotechnology to engineer exosomes displaying folate (FA).
• Employing fluorescence colocalization analysis to track siRNA payload delivery.
• Conducting gene knockdown assays to confirm gene silencing efficacy.
• Evaluating tumor regression in animal models.

Main Results:

• FA-displaying exosomes facilitate receptor-mediated delivery of siRNA payload directly into the cytosol.
• The delivery mechanism successfully bypasses endosome trapping, a common hurdle in targeted therapies.
• Demonstrated significant cancer suppression and tumor regression in vivo.
• Confirmed effective gene knockdown through the delivered siRNA.

Conclusions:

• The efficient cancer suppression by FA-exosomes is attributed to direct cytosolic siRNA delivery, avoiding endosomal entrapment.
• This mechanism highlights the potential of FA-displaying exosomes as a potent platform for cancer gene therapy.
• The findings may revitalize interest in using folate as a targeting ligand in human cancer treatment.